{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-067481","form_type":"8-K","ticker":"ITRMF","cik":"0001659323","company_name":"Iterum Therapeutics plc","filed_at":"2023-12-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.971273+00:00","generated_at":"2026-06-07T18:46:30.635185+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Iterum regains Nasdaq compliance with minimum bid price rule","bullets":["Received letter from Nasdaq on Dec 4, 2023 confirming compliance with Bid Price Rule.","Previously notified of deficiency on Sept 26, 2023; compliance deadline was March 25, 2024.","Achieved minimum $1.00 closing bid price for 10 consecutive trading days through Nov 30, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-067481","json":"https://secwatch.observer/filing/0000950170-23-067481.json","markdown":"https://secwatch.observer/filing/0000950170-23-067481.md","text":"https://secwatch.observer/filing/0000950170-23-067481.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659323/000095017023067481/0000950170-23-067481-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659323/000095017023067481/itrm-20231204.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T18:46:30.635185+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}